{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:27:13Z","timestamp":1778182033644,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.rec.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T18:17:13Z","timestamp":1616869033000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism"],"prefix":"10.1016","volume":"75","author":[{"given":"Carlos","family":"Puig-Jov\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Castelblanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Falguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Juli\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Teis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Julve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Barranco-Altirriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2021.02.006_bib0170","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2021.02.006_bib0175","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.006_bib0180","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rec.2021.02.006_bib0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2021.02.006_bib0190","doi-asserted-by":"crossref","first-page":"e005549","DOI":"10.1161\/JAHA.117.005549","article-title":"Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol","volume":"6","author":"Lawler","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2021.02.006_bib0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","article-title":"HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2021.02.006_bib0200","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.rec.2021.02.006_bib0205","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2021.02.006_bib0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.rec.2021.02.006_bib0215","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem."},{"key":"10.1016\/j.rec.2021.02.006_bib0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12933-016-0415-4","article-title":"Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study","volume":"15","author":"Valensi","year":"2016","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.rec.2021.02.006_bib0225","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD","volume":"101","author":"Bril","year":"2016","journal-title":"Clin Endocrinol Metab."},{"key":"10.1016\/j.rec.2021.02.006_bib0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-018-0706-z","article-title":"Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes","volume":"17","author":"Carbonell","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.rec.2021.02.006_bib0235","doi-asserted-by":"crossref","first-page":"e015158","DOI":"10.1136\/bmjopen-2016-015158","article-title":"Prevalence, clinical features and risk assessment of pre-diabetes in Spain: the prospective Mollerussa cohort study","volume":"7","author":"Vilanova","year":"2017","journal-title":"BMJ Open."},{"key":"10.1016\/j.rec.2021.02.006_bib0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2016.02.014","article-title":"Nuclear Magnetic Resonance Lipoprotein Abnormalities in Newly-Diagnosed Type 2 Diabetes and Their Association With Preclinical Carotid Atherosclerosis","volume":"247","author":"Amor","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2021.02.006_bib0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12933-015-0196-1","article-title":"Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy","volume":"14","author":"Alonso","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.rec.2021.02.006_bib0250","doi-asserted-by":"crossref","unstructured":"ADA. American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016. Diabetes Care. 2016;39:S13-S22.","DOI":"10.2337\/dc16-S005"},{"key":"10.1016\/j.rec.2021.02.006_bib0255","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.rec.2021.02.006_bib0260","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res."},{"key":"10.1016\/j.rec.2021.02.006_bib0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.006_bib0270","doi-asserted-by":"crossref","unstructured":"Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study. Int J Clin Pract. 2021;75:e13610.","DOI":"10.1111\/ijcp.13610"},{"key":"10.1016\/j.rec.2021.02.006_bib0275","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1373\/clinchem.2004.032763","article-title":"Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study","volume":"7","author":"Freedman","year":"2004","journal-title":"Clin Chem."},{"key":"10.1016\/j.rec.2021.02.006_bib0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9150(81)90093-9","article-title":"Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey","volume":"39","author":"Wahl","year":"1981","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rec.2021.02.006_bib0285","article-title":"HDL (High-Density Lipoprotein) Subclasses","author":"El Khoudary","year":"2020","journal-title":"Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study. Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.rec.2021.02.006_bib0290","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jacl.2015.08.001","article-title":"Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men","volume":"9","author":"Guardiola","year":"2015","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.rec.2021.02.006_bib0295","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.006_bib0300","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000033222.75187.B9","article-title":"Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women","volume":"106","author":"Blake","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2021.02.006_bib0305","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.metabol.2004.09.002","article-title":"Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study","volume":"54","author":"Goff","year":"2005","journal-title":"Metabolism."},{"key":"10.1016\/j.rec.2021.02.006_bib0310","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2796.2012.02562.x","article-title":"Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men","volume":"272","author":"Wang","year":"2012","journal-title":"J Intern Med."},{"key":"10.1016\/j.rec.2021.02.006_bib0315","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.81.8.2512","article-title":"Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer","volume":"81","author":"Fielding","year":"1984","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.rec.2021.02.006_bib0320","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0026-0495(94)90007-8","article-title":"Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease","volume":"43","author":"Kahri","year":"1994","journal-title":"Metabolism."},{"key":"10.1016\/j.rec.2021.02.006_bib0325","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2337\/dc11-1679","article-title":"Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain)","volume":"35","author":"Vinagre","year":"2012","journal-title":"Diabetes Care."},{"key":"10.1016\/j.rec.2021.02.006_bib0330","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2012-3185","article-title":"Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: The Insulin Resistance Atherosclerosis Study","volume":"98","author":"Lorenzo","year":"2013","journal-title":"J Clin Endocrionol Metab."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721000736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585721000736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:00:44Z","timestamp":1761822044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585721000736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1885585721000736"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.006","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2021.07.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}